Advisor Group’s BioLife Solutions BLFS Stock Holding History

Advisor Group’s Portfolio BLFS Stock Details BLFS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$0	Hold	5	–	–	﹤0.01%	5305
2019 Q3	$0	Hold	5	–	–	﹤0.01%	5270
2019 Q2	$0	Sell	5 -100	-95%	-$1.74K	﹤0.01%	5225
2019 Q1	$2K	Hold	105	–	–	﹤0.01%	4935
2018 Q4	$1K	Hold	105	–	–	﹤0.01%	4930
2018 Q3	$2K	Buy	105 +100	+2,000%	+$1.98K	﹤0.01%	4828
2018 Q2	$0	Hold	5	–	–	﹤0.01%	4924
2018 Q1	$0	Hold	5	–	–	﹤0.01%	4945
2017 Q4	$0	Hold	5	–	–	﹤0.01%	4955
2017 Q3	$0	Hold	5	–	–	﹤0.01%	4833
2017 Q2	$0	Hold	5	–	–	﹤0.01%	4786
2017 Q1	$0	Sell	5 -3	-38%	-$6	﹤0.01%	4685
2016 Q4	$0	Hold	8	–	–	﹤0.01%	4501
2016 Q3	$0	Hold	8	–	–	﹤0.01%	4471
2016 Q2	$0	Buy	+8	New	+$14	﹤0.01%	4394

Other funds holding BLFS

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

SCM

Sandler Capital Management New York $193M AUM 77.14% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Advisor Group's BLFS Position: Q4 2019 in Review

Advisor Group held its BioLife Solutions (BLFS) position steady in Q4 2019 at 5 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #5305.

Advisor Group first reported a position in BLFS in Q2 2016 and has held it in 15 quarters since. The position peaked at $2K in Q1 2019. 80 funds tracked by Wall St. Rank hold BLFS as of Q4 2019.

Advisor Group held 5 shares of BioLife Solutions worth $0 as of Q4 2019.
Advisor Group left its BioLife Solutions share count unchanged in Q4 2019.
BioLife Solutions made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #5305 holding.
Advisor Group first reported a position in BioLife Solutions in Q2 2016 and has held it in 15 quarters since.
Advisor Group's BioLife Solutions position peaked at $2K in Q1 2019.
80 funds tracked by Wall St. Rank held BioLife Solutions as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.